A blood stabilizer and its application
A blood stabilizer and blood technology, applied in the field of blood stabilizers, can solve the problems of not being able to provide DNA/RNA denaturation, and achieve the effect of preventing nucleated cell rupture, avoiding concentration increase, and preventing degradation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] An embodiment of the blood stabilizer described in the present invention, the blood stabilizer described in the present embodiment comprises the components of the following concentrations:
[0026]
[0027] Wherein, the concentrations of the potassium dichromate and lecithin are mass percent concentrations.
[0028] The preparation method of the blood stabilizer described in the present embodiment is: at first, calculate β-cyclodextrin (molecular weight is 1135), disodium cromoglycate ( Molecular weight is 248.3), triflusal (molecular weight is 248.2), EDTA tripotassium salt (molecular weight is 406.5), and according to the total mass of blood stabilizer and the mass percentage concentration of its components, potassium dichromate and lecithin are calculated Then, weigh each component in the blood stabilizer according to the calculation result; finally, add the weighed components into a volumetric flask, add water to dissolve, and constant volume.
Embodiment 2
[0030] An embodiment of the blood stabilizer described in the present invention, the blood stabilizer described in the present embodiment comprises the components of the following concentrations:
[0031]
[0032]
[0033] Wherein, the concentrations of the potassium dichromate and lecithin are mass percent concentrations.
[0034] The preparation method of the blood stabilizer described in this embodiment is the same as that in Example 1.
Embodiment 3
[0036] An embodiment of the blood stabilizer described in the present invention, the blood stabilizer described in the present embodiment comprises the components of the following concentrations:
[0037]
[0038] Wherein, the concentrations of the potassium dichromate and lecithin are mass percent concentrations.
[0039] The preparation method of the blood stabilizer described in this embodiment is the same as that in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com